179 Direct Oral Anticoagulants in End State Renal Disease
44.4%), followed by pulmonary embolism or a combination of pulmonary embolism and deep vein thrombosis.Limited mobility due to travel or acute illness was the most frequently reported provoking factor, affecting 44% of patients, with surgery being the second most common factor (22%).Thrombophilia work-up was conducted in 33% of cases, yielding positive results based on clinical presentation or a significant family history of blood clotting disorders.However, in only 11% of patients, the findings from thrombophilia testing led to a change in the management plan, resulting in lifelong anticoagulation. Conclusion:The findings of this study provide real-world data on patients attending Qatar's largest anticoagulation clinic, serving as a foundation for generating hypotheses for future anticoagulation research.
Authors
- Jawed Fareed (ORCID: https://orcid.org/0000-0003-3465-2499)
- Atul Prabhu (ORCID: https://orcid.org/0000-0003-0605-1514)
- Balbir Singh
- Atul Laddu
- H Pabbathi
- Anvi Peddi
Institutions
- Loyola University Chicago (US)
Publication Details
- Journal
- Research and Practice in Thrombosis and Haemostasis
- Published
- 2025-05-01
- DOI
- https://doi.org/10.1016/j.rpth.2025.102829
- Primary Topic
- Renal and Vascular Pathologies
- Type
- article
- Field-Weighted Citation Impact
- 0.00